Medindia

X

Alliar - Material Fact - Approval of the Share Buyback Plan

Wednesday, November 23, 2016 General News J E 4
Advertisement

BELO HORIZONTE, Brazil, Nov. 22, 2016 /PRNewswire/ -- Alliar - Centro de Imagem Diagnosticos S.A. (BM&FBOVESPA:AALR3), in accordance with Article 157, paragraph 4 of Law 6,404/76 and Instruction 358/02 of the Brazilian Securities and Exchange Commission (CVM), hereby informs its shareholders and the market in general that its Board of Directors approved today the Company's Share Buyback Program, through which the Company may acquire up to one million (1,000,000) non-par, registered, book-entry common shares, equivalent to approximately 2.28% of all its common shares on free float, in accordance with the following conditions:

  • Purpose of the Share Buyback Program: Acquisition of Company shares to be held in treasury for future sale (i)  in the scope of the Company's Long-term Incentive Plan with Restricted Measures approved at the Extraordinary Shareholders' Meeting of August 26, 2016, as amended at the Extraordinary Shareholders' Meeting of October 3, 2016; and (ii) in the scope of the acquisitions of companies in line with the Company's expansion plan already announced to the market, pursuant to the applicable regulations.
  • Acquisition period: The shares object of the Share Buyback Program will be acquired in up to eighteen (18) months, between November 23, 2016 and May 22, 2018. The members of the Company's Board of Executive Officers will determine the best time for acquiring the shares.
  • Funds to be used on the acquisition: The shares under the scope of the Share Buyback Program will be acquired with funds from the Company's "Capital Reserve" account.
  • Authorized financial institutions: The shares under the scope of the Share Buyback Program will be acquired on the BM&FBOVESPA, with the intermediation of Bank of America Merrill Lynch and Itau Corretora.

Additional information on the Share Buyback Program, including the information required under CVM Instructions 567/15 and 480/09, will be available to the shareholders on the Company's headquarters, on its Investor Relations website (http://ri.alliar.com), and on the websites of the Brazilian Securities and Exchange Commission (www.cvm.gov.br) and the BM&FBOVESPA (www.bmfbovespa.com.br).

CENTRO DE IMAGEM DIAGNOSTICOS S.A.Carlos Thiago de Souza AraujoInvestor Relations Officer+55 11 5088-1050

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/alliar---material-fact---approval-of-the-share-buyback-plan-300367646.html

SOURCE Alliar - Centro de Imagem Diagnosticos S.A.

Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Propanc Health Group Corporation to Webcast, Live,...
S
QView Medical Inc. Announces FDA PMA Approval for ...